Site Map
Posts
- Category: Wp Feeds (continued)
- IAC: HAART Brings Down Liver Enzymes (CME/CE)
- IAC: Tragedy, Low Attendance Won't Stop Meeting
- IBD May Up Postop DVT, Pulmonary Embolism Risk (CME/CE)
- IBD Meds Appear Safe in Pregnancy (CME/CE)
- IBD on the Rise in Canadian Kids
- IBD Therapy Lasts Longer With Crohn's (CME/CE)
- IBD Tied to Higher Risk for Heart Trouble
- IBS Drug Warrants Phase III Trial
- IBS, a Growing Problem for Med Students: Gastro and EndoNews Report
- ICAAC/ICC: Ebola, HIV Research on Tap
- ICD-10 Mostly an Easy Ride
- ICD-10: So Far, So Good
- ICD-10: What if it Was All a Joke?
- ID Briefs: Mumps, MERS, and Money
- IDSA Video Conference Reporter: AASLD 2017
- IDSA Video Conference Reporter: EASL 2017
- IDSA: HCV Drug Shows Promise in HIV (CME/CE)
- IDSA: Mild Liver Impairment Doesn't Interfere With Efavirenz (CME/CE)
- IDWeek Themes Range from MERS to Bad Bugs
- IDWeek: Zika Gets its Turn in Spotlight
- If Dad's the Liver Donor, Jr. May Not Need Immune Suppressants (CME/CE)
- If Targeted Treatments Work, Will Targeted Lobbying?
- IL-23: Good Target in Crohn's? (CME/CE)
- IL-6 and GI Perforations: A Link in RA? (CME/CE)
- Imaging No Help in Gallbladder Surgery Risk (CME/CE)
- iMedicalApps: App Aids Vascular Access Decisions
- Immune Therapies Active in GI Cancers
- Immune Therapy Safe in Early Trial (CME/CE)
- Immune Therapy Tames Colitis Flares (CME/CE)
- Immunosuppressed Kids Lose HBV Protection (CME/CE)
- Immunotherapy Duo Ups Survival in Pancreatic Ca
- Immunotherapy Patch for Crohn's Disease?
- Impact of New Agents: Hepatitis C
- Improved Scope Detects More Colon Polyps (CME/CE)
- Improving Colonoscopy: Lose the Liquid Diet? (CME/CE)
- In Blood Cancers, Transplants Safer than Before (CME/CE)
- In This Wave of Respiratory Illness, Primary Care Is Drowning
- Inadequate Treatment for Moms: Gastro and Endo News Report
- Incomplete HCV Testing Common, CDC Says (CME/CE)
- Increases in Myopia Progression in Kids Tied to the COVID Pandemic
- Infection Site Predicts Death in Septic Shock (CME/CE)
- Inflammation New Target in Colon Disorder (CME/CE)
- Infliximab Biosimilar: Getting Closer to Interchangeability (CME/CE)
- Information Blockade Ahead!
- Infusion-Based Therapies Show Promise in HBV (CME/CE)
- Injection Eases Fecal Incontinence (CME/CE)
- Inpatient COVID-19 Costs Substantially Outpaced Medical Inflation
- Insulin Glargine Not a Cancer Risk (CME/CE)
- Insurer Group to Pilot Program for Improving Doc Directories
- Insurers, Academics Protest High-Cost Drugs, Propose Solutions
